Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Insight Research Institute
Age
55–90
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Subject with Alzheimer's Disease Only: diagnosed according the NIA-AA diagnostic AD criteria
Healthy Control Only: Subject does not have history of cognitive impairment
55 - 90 years old
Subject able to comply with study procedures
Subjects must be able to use the Tasso device for blood sample collection as per the provided instructions (can be performed with the assistance of a caregiver)
Subjects must be able to undergo IV sampling
Have a study partner who will provide written informed consent to participate, and assist with blood collection when applicable
You may not be if
Subjects with systemic conditions which were not adequately controlled through a stable medication regimen
Subjects with any known significant bleeding disorders or conditions that contraindicate blood sample collection (e.g., hemophilia, severe thrombocytopenia)
Subjects with a known history of severe skin allergies or reactions to adhesives (since the Tasso device involves adhesive application to the skin)
Subjects currently taking anticoagulant or antiplatelet medications that could interfere with blood collection or increase the risk of complications
Subjects who have undergone major surgery or have been hospitalized for any reason in the last 3 months prior to study enrollment
Participation in a clinical study within the 2 month
Clareo Health | Home Test for Measuring Plasma P-tau217 in Alzheimer's Disease
